Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 429-432

  Tian, Guo Bao ^a,b   Adams Haduch, Jennifer M ^a   Bogdanovich, Tatiana ^a   Pasculle, Anthony W ^a,c   Quinn, John P ^d,e   Wang, Hong Ning ^b   Doi, Yohei ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Clinical Microbiology Laboratory   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^e SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; MOLECULAR SCAFFOLD;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; ESCHERICHIA COLI; FEMALE; GENETIC ANALYSIS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OXA 160 GENE; OXA 40 GENE; OXA 72 GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUBSTITUTION REACTION; UNITED STATES;

ACINETOBACTER BAUMANNII; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FLUOROQUINOLONES; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENNSYLVANIA;

EID: 78650658424     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01155-10     Document Type: Article

References (17)

1. Adams-Haduch, J. M., D. L. Paterson, H. E. Sidjabat, A. W. Pasculle, B. A. Potoski, C. A. Muto, L. H. Harrison, and Y. Doi. 2008. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob. Agents Chemother. 52:3837-3843.
2. Bartual, S. G., H. Seifert, C. Hippler, M. A. Luzon, H. Wisplinghoff, and F. Rodriguez-Valera. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382-4390.
3. Candel, F. J., N. Calvo, J. Head, A. Sanchez, M. Matesanz, E. Culebras, A.Barrientos, and J. Picazo. 2010. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev. Esp. Quimioter. 23:103-108.
4. Castanheira, M., A. Wanger, M. Kruzel, L. M. Deshpande, and R. N. Jones. 2008. Emergence and clonal dissemination of OXA-24-and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program. J. Clin. Microbiol. 46:3179-3180.
5. D'Andrea, M. M., T. Giani, S. D'Arezzo, A. Capone, N. Petrosillo, P. Visca, F. Luzzaro, and G. M. Rossolini. 2009. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:3528-3533.
6. Di Popolo, A., M. Giannouli, M. Triassi, S. Brisse, and R. Zarrilli. 28 April 2010. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infect. [Epub ahead of print.] doi: 10.1111/j.1469-0691.2010.03254.x.
7. Lee, K., M. N. Kim, T. Y. Choi, S. E. Cho, S. Lee, D. H. Whang, D. Yong, Y. Chong, N. Woodford, and D. M. Livermore. 2009. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int. J. Antimicrob. Agents 33:520-524.
8. Lolans, K., T. W. Rice, L. S. Munoz-Price, and J. P. Quinn. 2006. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50:2941-2945.
9. Lu, P. L., M. Doumith, D. M. Livermore, T. P. Chen, and N. Woodford. 2009. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J. Antimicrob. Chemother. 63:641-647.
10. Martinovich, A., M. Edelstein, and R. Kozlov. 2009. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-626.
11. Mengoni, A., S. Ricci, M. Brilli, F. Baldi, and R. Fani. 2007. Sequencing and analysis of plasmids pAV1 and pAV2 of Acinetobacter venetianus VE-C3 involved in diesel fuel degradation. Ann. Microbiol. 57:521-526.
12. Merino, M., J. Acosta, M. Poza, F. Sanz, A. Beceiro, F. Chaves, and G. Bou. 2010. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob. Agents Chemother. 54:2724-2727.
13. Naas, T., and P. Nordmann. 1999. OXA-type β-lactamases. Curr. Pharm. Des. 5:865-879.
14. Peleg, A. Y., H. Seifert, and D. L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
15. Sambrook, J., and D. Russell. 2001. Molecular cloning: a laboratory manual (third edition). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Santillana, E., A. Beceiro, G. Bou, and A. Romero. 2007. Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 104:5354-5359.
17. Wang, H., P. Guo, H. Sun, H. Wang, Q. Yang, M. Chen, Y. Xu, and Y. Zhu. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents Chemother. 51:4022-4028.